D'Argento, Ettore
D'Argento, Ettore
Collagenous colitis and atezolizumab therapy: an atypical case.
2021-01-01 Gallo, Antonella; Talerico, Rosella; Novello, Luca; Giustiniani, Maria Cristina; D'Argento, Ettore; Bria, Emilio; Montalto, Massimo
Masaoka-koga and tnm staging system in thymic epithelial tumors: Prognostic comparison and the role of the number of involved structures
2021-01-01 Chiappetta, M.; Lococo, F.; Pogliani, L.; Sperduti, I.; Tabacco, D.; Bria, E.; D'argento, E.; Massaccesi, M.; Boldrini, L.; Meacci, E.; Porziella, V.; Nachira, D.; Congedo, M. T.; Margaritora, S.
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors
2021-01-01 Ferrara, M. G.; Martini, M.; D'Argento, E.; Forcella, C.; Vita, E.; Di Noia, V.; Sperduti, I.; Bilotta, M.; Ribelli, M.; Damiano, P.; Cannella, A.; Stefani, A.; Pilotto, S.; Carbone, C.; Piro, G.; Milella, M.; Tortora, G.; Bria, E.
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study
2020-01-01 Di Noia, V.; D'Argento, E.; Pilotto, S.; Vita, E.; Ferrara, M. G.; Damiano, P.; Ribelli, M.; Cannella, A.; Virtuoso, A.; Fattorossi, A.; Ceresoli, G. L.; Milella, M.; Beretta, G. D.; Tortora, G.; Bria, E.
Oncogene-addicted non-small-cell lung cancer: Treatment opportunities and future perspectives
2020-01-01 Ferrara, M. G.; Di Noia, V.; D'argento, E.; Vita, E.; Damiano, P.; Cannella, A.; Ribelli, M.; Pilotto, S.; Milella, M.; Tortora, G.; Bria, E.
Eficacy of topical beta-blockers in the management of EGFR-inhibitor induced paronychia and pyogenic granuloma-like lesions: Case series and review of the literature
2019-01-01 Sollena, P.; Mannino, M.; Tassone, F.; Alessandra, M.; D'Argento, E.; Peris, K.
Exploring the molecular and biological background of lung neuroendocrine tumours
2019-01-01 Simbolo, M.; Di Noia, V.; D'Argento, E.; Milella, M.; Scarpa, A.; Tortora, G.; Bria, E.; Pilotto, S.
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: A systematic review and meta-analysis
2019-01-01 Rossi, A.; Noia, V. D.; Gkountakos, A.; D'Argento, E.; Sartori, G.; Vita, E.; Monteverdi, S.; Lombardo, F.; Iacovelli, R.; Carbognin, L.; Sperduti, I.; Milella, M.; Tortora, G.; Bria, E.; Pilotto, S.
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors
2019-01-01 Iezzi, R; Larici, A R; Posa, A; Carchesio, F; Congedo, M T; Tagliaferri, L; Cassano, A; D'argento, E; Mantini, G; Rodolfino, E; Margaritora, S; Bria, E; Tortora, G; Valentini, V; Manfredi, R
Molecular Testing in EBUS-TBNA Specimens of Lung Adenocarcinoma: A Study of Concordance Between Cell Block Method and Liquid-Based Cytology in Appraising Sample Cellularity and EGFR Mutations
2018-01-01 Magnini, Daniele; Fuso, Leonello; Varone, Francesco; D'Argento, Ettore; Martini, Maurizio; Pecoriello, Antonietta; Di Noia, Vincenzo; Arciuolo, Damiano; Fadda, Guido; Rindi, Guido; Richeldi, Luca
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium
2018-01-01 Schinzari, Giovanni; Rossi, Ernesto; Pierconti, Francesco; Garufi, Giovanna; Monterisi, Santa; Strippoli, Antonia; D'Argento, Ettore; Cassano, Alessandra; Barone, Carlo
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?
2017-01-01 Rossi, S; Basso, M; Strippoli, A; Schinzari, G; D'Argento, E; Larocca, M; Cassano, A; Barone, C
Are TKIs favourable for the elderly with non-small-cell lung cancer?
2016-01-01 Rossi, Sabrina; D'Argento, Ettore; Schinzari, Giovanni; Dadduzio, Vincenzo; Di Noia, Vincenzo Pio; Cassano, Alessandra; Barone, Carlo Antonio
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis.
2016-01-01 Rossi, Sabrina; D'Argento, Ettore; Basso, Michele; Strippoli, Antonia; Dadduzio, Vincenzo; Cerchiaro, Eleonora; Martini, Marco; Cassano, Alessandra; Barone, Carlo Antonio; Martini, Maurizio
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis.
2016-01-01 Strippoli, Antonia; Rossi, Sabrina; Martini, Marco; Basso, Michele; D'Argento, Ettore; Schinzari, Giovanni; Barile, Rosalba; Cassano, Alessandra; Barone, Carlo Antonio; Martini, Maurizio
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer?
2016-01-01 D'Argento, Ettore; Rossi, Sabrina; Schinzari, Giovanni; Strippoli, Antonia; Basso, Michele; Cassano, Alessandra; Barone, Carlo Antonio
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis
2016-01-01 Rodriquenz, Maria Grazia; Rossi, Sabrina; Ricci, Riccardo; Martini, Maurizio; Larocca, Mario; Dipasquale, Angelo; Quirino, Michela; Schinzari, Giovanni; Basso, Michele; D'Argento, Ettore; Strippoli, Antonia; Barone, Carlo Antonio; Cassano, Alessandra
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review.
2016-01-01 Rossi, Sabrina; Schinzari, Giovanni; Basso, Michele; Strippoli, Antonia; Dadduzio, Vincenzo; D'Argento, Ettore; Cassano, Alessandra; Barone, Carlo Antonio
| Data di pubblicazione | Titolo | Autore(i) | File |
|---|---|---|---|
| 1-gen-2021 | Collagenous colitis and atezolizumab therapy: an atypical case. | Gallo, Antonella; Talerico, Rosella; Novello, Luca; Giustiniani, Maria Cristina; D'Argento, Ettore; Bria, Emilio; Montalto, Massimo | |
| 1-gen-2021 | Masaoka-koga and tnm staging system in thymic epithelial tumors: Prognostic comparison and the role of the number of involved structures | Chiappetta, M.; Lococo, F.; Pogliani, L.; Sperduti, I.; Tabacco, D.; Bria, E.; D'argento, E.; Massaccesi, M.; Boldrini, L.; Meacci, E.; Porziella, V.; Nachira, D.; Congedo, M. T.; Margaritora, S. | |
| 1-gen-2021 | PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors | Ferrara, M. G.; Martini, M.; D'Argento, E.; Forcella, C.; Vita, E.; Di Noia, V.; Sperduti, I.; Bilotta, M.; Ribelli, M.; Damiano, P.; Cannella, A.; Stefani, A.; Pilotto, S.; Carbone, C.; Piro, G.; Milella, M.; Tortora, G.; Bria, E. | |
| 1-gen-2020 | Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study | Di Noia, V.; D'Argento, E.; Pilotto, S.; Vita, E.; Ferrara, M. G.; Damiano, P.; Ribelli, M.; Cannella, A.; Virtuoso, A.; Fattorossi, A.; Ceresoli, G. L.; Milella, M.; Beretta, G. D.; Tortora, G.; Bria, E. | |
| 1-gen-2020 | Oncogene-addicted non-small-cell lung cancer: Treatment opportunities and future perspectives | Ferrara, M. G.; Di Noia, V.; D'argento, E.; Vita, E.; Damiano, P.; Cannella, A.; Ribelli, M.; Pilotto, S.; Milella, M.; Tortora, G.; Bria, E. | |
| 1-gen-2019 | Eficacy of topical beta-blockers in the management of EGFR-inhibitor induced paronychia and pyogenic granuloma-like lesions: Case series and review of the literature | Sollena, P.; Mannino, M.; Tassone, F.; Alessandra, M.; D'Argento, E.; Peris, K. | |
| 1-gen-2019 | Exploring the molecular and biological background of lung neuroendocrine tumours | Simbolo, M.; Di Noia, V.; D'Argento, E.; Milella, M.; Scarpa, A.; Tortora, G.; Bria, E.; Pilotto, S. | |
| 1-gen-2019 | PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: A systematic review and meta-analysis | Rossi, A.; Noia, V. D.; Gkountakos, A.; D'Argento, E.; Sartori, G.; Vita, E.; Monteverdi, S.; Lombardo, F.; Iacovelli, R.; Carbognin, L.; Sperduti, I.; Milella, M.; Tortora, G.; Bria, E.; Pilotto, S. | |
| 1-gen-2019 | Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors | Iezzi, R; Larici, A R; Posa, A; Carchesio, F; Congedo, M T; Tagliaferri, L; Cassano, A; D'argento, E; Mantini, G; Rodolfino, E; Margaritora, S; Bria, E; Tortora, G; Valentini, V; Manfredi, R | |
| 1-gen-2018 | Molecular Testing in EBUS-TBNA Specimens of Lung Adenocarcinoma: A Study of Concordance Between Cell Block Method and Liquid-Based Cytology in Appraising Sample Cellularity and EGFR Mutations | Magnini, Daniele; Fuso, Leonello; Varone, Francesco; D'Argento, Ettore; Martini, Maurizio; Pecoriello, Antonietta; Di Noia, Vincenzo; Arciuolo, Damiano; Fadda, Guido; Rindi, Guido; Richeldi, Luca | |
| 1-gen-2018 | Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium | Schinzari, Giovanni; Rossi, Ernesto; Pierconti, Francesco; Garufi, Giovanna; Monterisi, Santa; Strippoli, Antonia; D'Argento, Ettore; Cassano, Alessandra; Barone, Carlo | |
| 1-gen-2017 | Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? | Rossi, S; Basso, M; Strippoli, A; Schinzari, G; D'Argento, E; Larocca, M; Cassano, A; Barone, C | |
| 1-gen-2016 | Are TKIs favourable for the elderly with non-small-cell lung cancer? | Rossi, Sabrina; D'Argento, Ettore; Schinzari, Giovanni; Dadduzio, Vincenzo; Di Noia, Vincenzo Pio; Cassano, Alessandra; Barone, Carlo Antonio | |
| 1-gen-2016 | Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis. | Rossi, Sabrina; D'Argento, Ettore; Basso, Michele; Strippoli, Antonia; Dadduzio, Vincenzo; Cerchiaro, Eleonora; Martini, Marco; Cassano, Alessandra; Barone, Carlo Antonio; Martini, Maurizio | |
| 1-gen-2016 | ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. | Strippoli, Antonia; Rossi, Sabrina; Martini, Marco; Basso, Michele; D'Argento, Ettore; Schinzari, Giovanni; Barile, Rosalba; Cassano, Alessandra; Barone, Carlo Antonio; Martini, Maurizio | |
| 1-gen-2016 | From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? | D'Argento, Ettore; Rossi, Sabrina; Schinzari, Giovanni; Strippoli, Antonia; Basso, Michele; Cassano, Alessandra; Barone, Carlo Antonio | |
| 1-gen-2016 | Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis | Rodriquenz, Maria Grazia; Rossi, Sabrina; Ricci, Riccardo; Martini, Maurizio; Larocca, Mario; Dipasquale, Angelo; Quirino, Michela; Schinzari, Giovanni; Basso, Michele; D'Argento, Ettore; Strippoli, Antonia; Barone, Carlo Antonio; Cassano, Alessandra | |
| 1-gen-2016 | Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. | Rossi, Sabrina; Schinzari, Giovanni; Basso, Michele; Strippoli, Antonia; Dadduzio, Vincenzo; D'Argento, Ettore; Cassano, Alessandra; Barone, Carlo Antonio |